Uptake of a fluorescent deoxyglucose analog (2-NBDG) in tumor cells.
about
Englerin A stimulates PKCθ to inhibit insulin signaling and to simultaneously activate HSF1: pharmacologically induced synthetic lethalityCharacterization and performance of a near-infrared 2-deoxyglucose optical imaging agent for mouse cancer modelsOptical imaging of bacterial infectionsCancer imaging by optical coherence tomography: preclinical progress and clinical potential.Application of confocal laser endomicroscopy in the diagnosis and management of Barrett's esophagusThe sweet spot: FDG and other 2-carbon glucose analogs for multi-modal metabolic imaging of tumor metabolismVibrational Imaging of Glucose Uptake Activity in Live Cells and Tissues by Stimulated Raman ScatteringImaging metabolic heterogeneity in cancerCD47 agonist peptides induce programmed cell death in refractory chronic lymphocytic leukemia B cells via PLCγ1 activation: evidence from mice and humansPhotoacoustic Brain Imaging: from Microscopic to Macroscopic ScalesNoninvasive photoacoustic computed tomography of mouse brain metabolism in vivo.Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice.Dynamic near-infrared optical imaging of 2-deoxyglucose uptake by intracranial glioma of athymic mice.Evaluation and clinically relevant applications of a fluorescent imaging analog to fluorodeoxyglucose positron emission tomographyEstradiol promotes pentose phosphate pathway addiction and cell survival via reactivation of Akt in mTORC1 hyperactive cells.Efficient mucosal delivery of optical contrast agents using imidazole-modified chitosanDevelopment of fluorescent glucose bioprobes and their application on real-time and quantitative monitoring of glucose uptake in living cells.Suppression of VAMP2 Alters Morphology of the Tegument and Affects Glucose uptake, Development and Reproduction of Schistosoma japonicumDisruption of the actin cytoskeleton induces fluorescent glucose accumulation on the rat hepatocytes Clone 9.Pre-clinical evaluation of fluorescent deoxyglucose as a topical contrast agent for the detection of Barrett's-associated neoplasia during confocal imaging.Fluorescent fructose derivatives for imaging breast cancer cellsMacrophage embedded fibrin gels: an in vitro platform for assessing inflammation effects on implantable glucose sensorsOsteopontin upregulates the expression of glucose transporters in osteosarcoma cells.Mitochondrial topoisomerase I is critical for mitochondrial integrity and cellular energy metabolism.Delivery-corrected imaging of fluorescently-labeled glucose reveals distinct metabolic phenotypes in murine breast cancerTechniques to monitor glycolysis.Delivery rate affects uptake of a fluorescent glucose analog in murine metastatic breast cancer.Wide-field imaging of fluorescent deoxy-glucose in ex vivo malignant and normal breast tissue.Fiber-optic system for dual-modality imaging of glucose probes 18F-FDG and 6-NBDG in atherosclerotic plaquesTargeting ABL1-mediated oxidative stress adaptation in fumarate hydratase-deficient cancer.IKKβ and NF-κB transcription govern lymphoma cell survival through AKT-induced plasma membrane trafficking of GLUT1.Assessing glucose uptake through the yeast hexose transporter 1 (Hxt1).Fluorescence and reflectance spectral imaging system for a murine mammary window chamber modelMarine Bromophenol Derivative 3,4-Dibromo-5-(2-bromo-3,4-dihydroxy-6-isopropoxymethyl benzyl)benzene-1,2-diol Protects Hepatocytes from Lipid-Induced Cell Damage and Insulin Resistance via PTP1B Inhibition.Imaging hamster model of bile duct cancer in vivo using fluorescent L-glucose derivativesOptical molecular imaging of multiple biomarkers of epithelial neoplasia: epidermal growth factor receptor expression and metabolic activity in oral mucosa.2-NBDG fluorescence imaging of hypermetabolic circulating tumor cells in mouse xenograft model of breast cancerCancer cell spheroids are a better screen for the photodynamic efficiency of glycosylated photosensitizers.Uptake of a fluorescent L-glucose derivative 2-NBDLG into three-dimensionally accumulating insulinoma cells in a phloretin-sensitive manner.Glucosamine-bound near-infrared fluorescent probes with lysosomal specificity for breast tumor imaging.
P2860
Q24311618-0F710964-8626-4D13-BB8A-1CBED5DC9CCAQ24657493-1D55BC89-3379-4BCA-A9F8-8F0151F918B9Q26747217-5E9BB402-D36B-40F9-922D-0FC8BB8BD03BQ26823084-3F4C06AB-4752-4C1C-85BB-FB1C3B3B7094Q26996365-1765F938-9E6E-4833-BE0B-F2E20751F601Q26999434-1E091F96-B989-4E5C-8004-2A27D24312DFQ27339639-23347C24-31E5-470B-A356-DC4C6A443D3CQ28076500-B6FF4B9E-4731-44FF-BD6C-5D46ADC0A9A6Q28543785-FBF493EC-D38F-4CAB-8DCA-61F7E8B54914Q30426250-57702D19-3550-49BA-BD4A-5AB89A6A75E7Q30459610-5DAC7EDD-04BB-4D4D-8441-F50AF25FB227Q33243608-9C76815B-08DF-42D2-BA0A-6F330C857C7EQ33517126-C256DC30-33D6-4B26-83BD-F5AA827EB3E0Q33522737-844D3650-8830-4BD8-B776-520E9B651C0AQ33720145-C985668B-BDE3-4F58-AAFF-7D5AACA4EB5FQ33731655-F54A7995-9348-4949-8EEA-0C57049456DFQ33786017-8BCA2D9A-692F-4428-BBD5-6F030BBF0576Q33899345-CC9152A3-3639-4B6E-A10E-76D9EE435768Q33937997-B4288D1A-427B-4178-8BE4-073E072E1932Q34011842-F0092D38-3930-43E0-8C7F-E94C6CAB8FB1Q34094417-BD0A8F7D-7A3B-4BBF-97AD-C7D39847B10AQ34183991-A26B3409-4BDE-47FC-BBC9-05F6F7DB5E6CQ34332053-C5E59327-8FB4-41DB-8FE2-6A5EE92DA384Q34387659-FBE548A2-63E9-43BA-B426-3D778DBCFE86Q34744489-8903C94D-A812-4FE8-9673-9762ED2D66DAQ34771393-2A31BC27-1224-4E89-952E-63E883D27E4CQ35034709-3456876D-2752-46DE-BF6F-F3C3C5051D25Q35042925-60050356-7DAB-40C5-A62E-7D7FA2E1FA1BQ35262149-5EF01686-7564-4A4E-BB22-70FF4C91EFAAQ35278899-D52FB32B-575E-43DF-8411-73B4AA17558FQ35587163-9036B2AD-5313-4165-9194-5475F3E3A077Q35588788-FC5790C4-EAF6-4466-A832-6F11359D1EB1Q35756406-E9BC60D5-E360-4F5B-A32B-000AB52235DFQ35890756-3F771633-70BC-452C-B0B3-B74A0C8DE41CQ35913881-281881F9-253C-406D-884D-5F74A6294863Q36061785-2838344D-50E3-4CAA-999B-0B9FC7433159Q36119176-5DF32A00-45E5-4E83-BCE2-E3FA1F1ACA17Q36381518-8D96FC84-A345-4E09-9FAC-4B2A10A80395Q36441699-EA447B9A-3615-45BB-BF5A-0FEB47DBF984Q36528213-3A34198F-5AC4-43B2-9031-8AB5C317E0B8
P2860
Uptake of a fluorescent deoxyglucose analog (2-NBDG) in tumor cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Uptake of a fluorescent deoxyglucose analog (2-NBDG) in tumor cells.
@en
type
label
Uptake of a fluorescent deoxyglucose analog (2-NBDG) in tumor cells.
@en
prefLabel
Uptake of a fluorescent deoxyglucose analog (2-NBDG) in tumor cells.
@en
P2093
P1476
Uptake of a fluorescent deoxyglucose analog (2-NBDG) in tumor cells.
@en
P2093
Nizar Mullani
Roger G O'Neil
P2888
P304
P356
10.1007/S11307-005-0011-6
P577
2005-11-01T00:00:00Z
P6179
1049718350